cancer

Can the high doses of chemotherapy and radiation that young cancer patients receive cause inherited health problems for their children?

Thanks to Vanderbilt-Ingram Cancer Center's new Clinical Trials Mentor Program, patients considering enrolling in a clinical trial can now ask questions and get first-hand accounts from patient advocates who have already gone through the process.

The Vanderbilt-Ingram Cancer Center has been chosen by the National Cancer Institute to join an elite group of researchers asked to test the most cutting-edge cancer treatments in Phase II clinical trials in both solid tumor and hematologic malignancies.

Researchers at the Vanderbilt-Ingram Cancer Center have uncovered a clue to explain the invasive nature of an aggressive kind of brain tumor called glioblastoma multiforme, or gliomas, and their findings are published in this week's online edition of the journal Oncogene.

The Vanderbilt-Ingram Cancer Center is leading a multi-institutional effort supported by the National Cancer Institute (NCI) to identify "molecular signatures" of lung cancer.

The U.S. Food and Drug Administration has approved the first new therapy in almost a decade for pancreas cancer, the fourth leading cause of cancer death in the United States.

When a woman is diagnosed with breast cancer, multiple clinic visits may begin to mount, along with questions that the patient wants answered sooner rather than later.